Cite
Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
MLA
Poenou G, et al. “Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future Perspectives.” Vascular Health and Risk Management, vol. ume 18, May 2022, pp. 359–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.285ab5acd3464106a322820082995b3a&authtype=sso&custid=ns315887.
APA
Poenou G, Dumitru Dumitru T, Lafaie L, Mismetti V, Heestermans M, & Bertoletti L. (2022). Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives. Vascular Health and Risk Management, ume 18, 359–373.
Chicago
Poenou G, Dumitru Dumitru T, Lafaie L, Mismetti V, Heestermans M, and Bertoletti L. 2022. “Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future Perspectives.” Vascular Health and Risk Management ume 18 (May): 359–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.285ab5acd3464106a322820082995b3a&authtype=sso&custid=ns315887.